A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)

Overview[ - collapse ][ - ]

Purpose This study will assess the effect of LCQ when added to metformin.
ConditionType 2 Diabetes Mellitus
InterventionDrug: LCQ908A
Drug: LCQ908A
Drug: LCQ908A
Drug: LCQ908A
Drug: LCQ908A
Drug: Placebo
Drug: Sitagliptin
Drug: metformin
PhasePhase 2
SponsorNovartis Pharmaceuticals
Responsible PartyNovartis
ClinicalTrials.gov IdentifierNCT00901979
First ReceivedMay 13, 2009
Last UpdatedJanuary 3, 2013
Last verifiedJanuary 2013

Tracking Information[ + expand ][ + ]

First Received DateMay 13, 2009
Last Updated DateJanuary 3, 2013
Start DateApril 2009
Estimated Primary Completion DateJune 2010
Current Primary Outcome MeasuresEffect of LCQ on measures of glucose control [Time Frame: 12 weeks] [Designated as safety issue: No]
Current Secondary Outcome Measures
  • Changes in body weight and related measures [Time Frame: 12 weeks] [Designated as safety issue: No]
  • Insulin sensitivity [Time Frame: 12 weeks] [Designated as safety issue: No]
  • Safety and tolerability [Time Frame: 12 weeks] [Designated as safety issue: Yes]

Descriptive Information[ + expand ][ + ]

Brief TitleA 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
Official TitleNot Provided
Brief Summary
This study will assess the effect of LCQ when added to metformin.
Detailed DescriptionNot Provided
Study TypeInterventional
Study PhasePhase 2
Study DesignAllocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
ConditionType 2 Diabetes Mellitus
InterventionDrug: LCQ908A
Drug: LCQ908A
Drug: LCQ908A
Drug: LCQ908A
Drug: LCQ908A
Drug: Placebo
Drug: Sitagliptin
Drug: metformin
Study Arm (s)
  • Experimental: LCQ908 Dose 1
  • Experimental: LCQ908 Dose 2
  • Experimental: LCQ908 Dose 3
  • Experimental: LCQ908 Dose 4
  • Experimental: LCQ908 Dose 5
  • Placebo Comparator: Placebo
  • Active Comparator: Sitagliptin

Recruitment Information[ + expand ][ + ]

Recruitment StatusCompleted
Estimated Enrollment693
Estimated Completion DateJune 2010
Estimated Primary Completion DateJune 2010
Eligibility Criteria
Inclusion Criteria:

- HbA1c from 7.0-10.0%, Stable Metformin dose

Exclusion Criteria:

- CHF Class III-IV, Liver disease

Other protocol-defined inclusion/exclusion criteria may apply
GenderBoth
Ages18 Years
Accepts Healthy VolunteersNo
ContactsNot Provided
Location CountriesUnited States, Argentina, Canada, Italy, Poland, Puerto Rico

Administrative Information[ + expand ][ + ]

NCT Number NCT00901979
Other Study ID NumbersCLCQ908A2203
Has Data Monitoring CommitteeNot Provided
Information Provided ByNovartis
Study SponsorNovartis Pharmaceuticals
CollaboratorsNot Provided
Investigators Not Provided
Verification DateJanuary 2013

Locations[ + expand ][ + ]

Mesa Family Medical Center/Clinical Research Advantage
Mesa, Arizona, United States
Clinical Research Advantage
Mesa, Arizona, United States
Woodland International Reserach Group, LLC
Little Rock, Arkansas, United States
Associated Pharmaceutical Research
Buena Park, California, United States
John Muir Clinical Research
Concord, California, United States
*Private Practice*
Pasadena, California, United States
Apex Research of Riverside
Riverside, California, United States
California Research Foundation
San Diego, California, United States
CNRI-San Diego, LLC
San Diego, California, United States
Orange County Research Center
Tustin, California, United States
Diablo Clinical
Walnut Creek, California, United States
Denver VA Medical Center
Denver, Colorado, United States
Complete Family Care
Northglenn, Colorado, United States
Research Center Phase I-IV of Florida, Corp.
Miami, Florida, United States
Metabolic Research Institute, Inc.
West Palm Beach, Florida, United States
Perimeter North Medical Research
Roswell, Georgia, United States
MacNeal Center for Clinical Research
Berwyn, Illinois, United States
Venture Resource Group
Overland Park, Kansas, United States
Cotton-O'Neil Clinical Research Center Topeka KS United States
Topeka, Kansas, United States
Graves Gilbert Clinic Bowling Green KY United States
Bowling Green, Kentucky, United States
Commonwealth Biomedical Research, LLC
Madisonville, Kentucky, United States
Centennial Medical Group
Elkridge, Maryland, United States
International Research Center Towson MD United States
Towson, Maryland, United States
Fallon Clinic Worcester MA United States
Worcester, Massachusetts, United States
Southwestern Medical Clinic
Bridgman, Michigan, United States
Clarkston Medical Group
Clarkston, Michigan, United States
Michigan State University - Kalamazoo Ctr for Med Studies
Kalamazoo, Michigan, United States
Mississippi Medical Research, LLC
Picayune, Mississippi, United States
St. John's Clinic - Medical Research
Springfield, Missouri, United States
ClinVest Research
Springfield, Missouri, United States
Montana Medical Research
Missoula, Montana, United States
Meera Dewan, P.C.
Omaha, Nebraska, United States
Libra Clinical Research Associates
Brick, New Jersey, United States
Physicians Research Center
Toms River, New Jersey, United States
Endwell Family Physician
Endwell, New York, United States
*Private Practice* Staten Island
Staten Island, New York, United States
Medical Frontiers LLC
Carlisle, Ohio, United States
Radiant Research
Greer, South Carolina, United States
Southwind Medical Specialists Memphis TN United States
Memphis, Tennessee, United States
Dallas Diabetic and Endocrinology Research Center
Dallas, Texas, United States
Radiant Research - North Dallas
Dallas, Texas, United States
Texas Center for Drug Development, P.A.
Houston, Texas, United States
Blalock Clinical Research
Houston, Texas, United States
Accurate Clinical Research
Houston, Texas, United States
Ettrick Health Center
Ettrick, Virginia, United States
McGuire Veterans Medical Center
Richmond, Virginia, United States
Northwest Clinical Research
Bellevue, Washington, United States
Providence Physicians Group
Monroe, Washington, United States
Rivergrove Medical Clinic
Winnipeg, Manitoba, Canada
Health Sciences Centre - Diabetes Research Group
Winnipeg, Manitoba, Canada
Credit Valley Prof Bldg
Mississauga, Ontario, Canada
Hamilton Medical Research Group
Sherbrooke, Ontario, Canada
Hopital Maisonneuve-Rosemont
Montreal, Quebec, Canada
Institut de Recherches Cliniques
Montreal, Quebec, Canada
Clinique Médicale Millénia Santé
Québec, Quebec, Canada
CHUS - Hopital Fleurimont
Sherbrooke, Quebec, Canada
Azienda Ospedaliera-Ospedali Riuniti di Bergamo
Bergamo, Italy
Centro Studi sull'Invecchiamento CeSI-Univers.G.D'Annunzio
Chieti, Italy
A.O.Polo Universitario Luigi Sacco
Milano, Italy
Istituto Scientifico San Raffaele - IRCCS
Milano, Italy
Ospedale S.Giovanni di Dio
Olbia, Italy
Presidio Ospedaliero di Cisanello Università degli Studi
Pisa, Italy
Univ.Tor Vergata - AUSL ROMA B - Sede Territoriale
Roma, Italy
Samodzielny Publiczny Zaklad Opieki Zdrowotnej
Olawa, Poland
Policlinica Dr. Luis Rodriguez Carrasquillo
Carolina, Puerto Rico
Endocrine Lipid Diabetes Research Institute Ponce PR United States
Ponce, Puerto Rico
Miguel Sosa-Padilla, M.D.
San Juan, Puerto Rico